INS and Insulin resistance: Fasting insulin and insulin resistance, as measured by euglycemic-hyperinsulinemic clamp, improved in the pioglitazone group, but neither exercise nor pioglitazone affected cognitive performance, and there was no interaction between improved glucose disposal rate and any domain of cognitive performance.